Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
Holding ORIC?
Track your performance easily

Oric Pharmaceuticals (ORIC) Financial Statements

293 Followers

Oric Pharmaceuticals Financial Overview

Oric Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.762; its P/E ratio is -5.32; Oric Pharmaceuticals is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -31.96M$ -28.99M$ -31.43M$ -25.48M$ -22.94M
EBITDA$ -29.46M$ -28.73M$ -31.16M$ -27.14M$ -23.95M
Net Income Common Stockholders$ -31.96M$ -25.01M$ -28.33M$ -25.48M$ -22.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 286.41M$ 316.78M$ 208.19M$ 227.30M$ 264.16M
Total Assets$ 328.91M$ 350.79M$ 252.01M$ 274.33M$ 291.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -286.41M$ -316.78M$ -208.19M$ -227.30M$ -264.16M
Total Liabilities$ 26.51M$ 22.14M$ 27.92M$ 26.92M$ 23.02M
Stockholders Equity$ 302.40M$ 328.68M$ 224.09M$ 247.41M$ 268.82M
Cash Flow-
Free Cash Flow$ -25.96M$ -30.40M$ -24.33M$ -19.72M$ -21.55M
Operating Cash Flow$ -25.63M$ -30.19M$ -24.27M$ -19.64M$ -21.14M
Investing Cash Flow$ 18.28M$ -61.87M$ 20.96M$ -57.83M$ -19.31M
Financing Cash Flow$ 816.00K$ 125.03M$ 453.00K$ 31.00K$ 85.17M
Currency in USD

Oric Pharmaceuticals Earnings and Revenue History

Oric Pharmaceuticals Debt to Assets

Oric Pharmaceuticals Cash Flow

Oric Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis